Met Life Investment Management, LLC Alx Oncology Holdings Inc Transaction History

Met Life Investment Management, LLC

$17.1 Billion
Q3 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$5.84 - $17.56 $9,221 - $27,727	1,579 Added 10.84%	16,140 $97,000
Q1 2024 May 14, 2024	BUY	$10.95 - $16.79 $159,442 - $244,479	14,561 New	14,561 $162,000
Q4 2023 Feb 14, 2024	BUY	$4.81 - $15.38 $70,038 - $223,948	14,561 New	14,561 $216,000
Q2 2023 Apr 29, 2024	BUY	$4.37 - $9.56 $50,499 - $110,475	11,556 New	11,556 $86,000
Q2 2023 Aug 10, 2023	BUY	$4.37 - $9.56 $50,499 - $110,475	11,556 New	11,556 $86,000
Q4 2022 Jun 14, 2023	BUY	$9.51 - $12.95 $111,790 - $152,227	11,755 New	11,755 $132,000
Q3 2022 May 10, 2024	BUY	$8.23 - $15.14 $8,312 - $15,291	1,010 Added 9.4%	11,755 $112,000
Q3 2022 Jun 14, 2023	BUY	$8.23 - $15.14 $96,743 - $177,970	11,755 New	11,755 $112,000
Q3 2022 Mar 22, 2023	BUY	$8.23 - $15.14 $8,312 - $15,291	1,010 Added 9.4%	11,755 $112,000
Q3 2022 Nov 14, 2022	BUY	$8.23 - $15.14 $96,743 - $177,970	11,755 New	11,755 $112,000
Q2 2022 Aug 11, 2022	SELL	$5.89 - $19.46 $63,288 - $209,097	-10,745 Closed	0 $0
Q1 2022 May 10, 2024	BUY	$13.65 - $22.06 $146,669 - $237,034	10,745 New	10,745 $181,000
Q1 2022 Jun 20, 2023	BUY	$13.65 - $22.06 $146,669 - $237,034	10,745 New	10,745 $181,000
Q1 2022 Mar 22, 2023	BUY	$13.65 - $22.06 $54,122 - $87,467	3,965 Added 58.48%	10,745 $181,000
Q1 2022 May 12, 2022	BUY	$13.65 - $22.06 $54,122 - $87,467	3,965 Added 58.48%	10,745 $182,000
Q4 2021 Jun 21, 2023	BUY	$21.49 - $74.4 $145,702 - $504,432	6,780 New	6,780 $145,000
Q3 2021 Jun 21, 2023	BUY	$52.51 - $80.91 $356,017 - $548,569	6,780 New	6,780 $500,000
Q1 2021 May 17, 2024	SELL	$62.84 - $87.68 $488,958 - $682,238	-7,781 Reduced 53.44%	6,780 $499,000
Q1 2021 Jun 26, 2023	BUY	$62.84 - $87.68 $426,055 - $594,470	6,780 New	6,780 $500 Million
Q1 2021 Mar 22, 2023	BUY	$62.84 - $87.68 $151,381 - $211,221	2,409 Added 55.11%	6,780 $499,000
Q1 2021 May 14, 2021	BUY	$62.84 - $87.68 $151,381 - $211,221	2,409 Added 55.11%	6,780 $500,000
Q4 2020 Jun 22, 2023	BUY	$34.11 - $112.26 $149,094 - $490,688	4,371 New	4,371 $376,000
Q3 2020 May 24, 2024	SELL	$29.36 - $47.1 $299,178 - $479,949	-10,190 Reduced 69.98%	4,371 $165 Million
Q3 2020 Jun 26, 2023	BUY	$29.36 - $47.1 $128,332 - $205,874	4,371 New	4,371 $164,000
Q3 2020 Mar 22, 2023	SELL	$29.36 - $47.1 $216,794 - $347,786	-7,384 Reduced 62.82%	4,371 $164,000
Q3 2020 Nov 13, 2020	BUY	$29.36 - $47.1 $128,332 - $205,874	4,371 New	4,371 $165,000

Others Institutions Holding ALXO

# of Institutions

101

Shares Held

39.7M

Call Options Held

134K

Put Options Held

17.4K

Ven Bio Partners LLC San Francisco, CA

9.7M
Shares

$17.8 Million
14.51% of portfolio
Tang Capital Management LLC San Diego, CA

4.2M
Shares

$7.69 Million
0.65% of portfolio
Vivo Capital, LLC Palo Alto, CA

4.03M
Shares

$7.38 Million
1.07% of portfolio
Redmile Group, LLC San Francisco, CA

3.84M
Shares

$7.02 Million
0.46% of portfolio
Black Rock Inc. New York, NY

2.69M
Shares

$4.92 Million
0.0% of portfolio

View Full List

About ALX ONCOLOGY HOLDINGS INC

Ticker ALXO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,747,100
Market Cap $74.6M
Description
ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...

More about ALXO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Account